Synthesis of new Hantzsch adducts showing Ca 2+ channel blockade capacity, cholinesterase inhibition and antioxidant power - Archive ouverte HAL Access content directly
Journal Articles Future Medicinal Chemistry Year : 2021

Synthesis of new Hantzsch adducts showing Ca 2+ channel blockade capacity, cholinesterase inhibition and antioxidant power

, , , , , (1)
1
Irene Pachón-Angona
  • Function : Author
Maciej Maj
Artur Wnorowski
Helene Martin
  • Function : Author
Krzysztof Jóźwiak

Abstract

Background: Alzheimer’s disease is a chronic neurodegenerative chronic disease with a heavy social and economic impact in our developed societies, which still lacks an efficient therapy. Method: This paper describes the Hantzsch multicomponent synthesis of twelve alkyl hexahydro-quinoline-3-carboxylates, 4a–l, along with the evaluation of their Ca 2+ channel blockade capacity, cholinesterase inhibition and antioxidant power. Results: Compound 4l showed submicromolar inhibition of butyrylcholinesterase, Ca 2+ channel antagonism and an antioxidant effect. Conclusion: Compound 4l is an interesting compound that deserves further investigation for Alzheimer’s disease therapy.
Not file

Dates and versions

hal-03654559 , version 1 (28-04-2022)

Identifiers

Cite

Irene Pachón-Angona, Maciej Maj, Artur Wnorowski, Helene Martin, Krzysztof Jóźwiak, et al.. Synthesis of new Hantzsch adducts showing Ca 2+ channel blockade capacity, cholinesterase inhibition and antioxidant power. Future Medicinal Chemistry, 2021, 13 (20), pp.1717-1729. ⟨10.4155/fmc-2021-0176⟩. ⟨hal-03654559⟩

Collections

UNIV-FCOMTE
4 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More